US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cannabis Concept

121.62

+2.772.33%

Number of Gainers:14

Number of Losers:2

Number of Flat:1

PE:- -

High:121.78

Open:118.85

Low:118.85

Close:118.85

Loading ...

Teva : Truist Securities Initiates Coverage With Buy Rating; Target Price $25

THOMSON REUTERS

BUZZ-Veru rises as combo drug shows fewer side effects than semaglutide alone in trial

Veru Reports Positive Safety Results From Phase 2B Quality Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone

THOMSON REUTERS

Veru Inc - Requests End of Phase 2 Meeting With FDA for Phase 3 Regulatory Clarity

THOMSON REUTERS

Veru Inc: Trial Met Its Prespecified Primary Endpoint

THOMSON REUTERS

Veru Inc - Topline Data for Phase 2B Extension Study Expected in Second Quarter

THOMSON REUTERS

NSW considers moving Sydney Harbour’s last working port for homes

The Australian Financial Review

Avecho Biotechnology Secures R&D Tax Incentive to Advance CBD Insomnia Treatment

Aurora Labs Enters U.S. Aerospace Market with Mayman Aerospace Partnership

Teva receives FDA Fast Track designation for TEV-53408, an anti-IL-15 antibody

Teva initiated with a Buy at Truist

Cumberland Pharmaceuticals Unveils Study Confirming Caldolor® as Safe and Effective Opioid-Sparing Pain Management for Older Adults

Cantor Fitzgerald Remains a Buy on Aurora Innovation (AUR)

Teva Pharmaceutical Industries Begins Preclinical Testing of Inflammation Drug BD9

MT Newswires Live

Teva and Biolojic Design Initiate Ind-Enabling Studies of Bd9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

THOMSON REUTERS

Teva Pharmaceutical Industries Ltd - Biolojic to Receive Milestone Payments for Bd9 Development

THOMSON REUTERS

Aurora Cannabis Announces Virtual Annual Meeting for August 2025

Organigram's CEO Beena Goldenberg to Retire in September

MT Newswires Live

Avecho Secures Major Partnership with Sandoz for CBD Sleep Treatment

What higher building heights could bring for Singapore’s land use and urban planning

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4557/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":121.62316,"timestamp":1749239999999,"preClose":118.85143,"halted":0,"volume":161707330,"delay":0,"changeRate":0.023321,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":2.771729,"latestTime":"06-06 16:00:00 EDT","open":118.85036,"high":121.775826,"low":118.85036,"amount":295105909.14203,"amplitude":0.024614,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.218363,"peRate":-18.470769,"turnoverRate":0.033701,"increases":14,"decrements":2,"flats":0,"marketCap":38243444631,"floatMarketCap":33357463398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":121.775826,"amplitude":0.024614,"preClose":118.85143,"low":118.85036,"pbRate":"2.218363","latestPrice":121.62316,"volume":161707330,"delay":0,"open":118.85036,"prevYearClose":144.8539,"prevWeekClose":115.0494,"prevMonthClose":115.0494,"prevQuarterClose":106.4635,"fiveDayClose":115.0494,"twentyDayClose":116.183,"sixtyDayClose":108.9365,"secType":"PLATE","market":"US","turnoverRate":0.033701,"peRate":-18.470769,"marketCap":38243444631,"floatMarketCap":33357463398,"timestamp":1749239999999,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":14,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538047827","title":"Teva : Truist Securities Initiates Coverage With Buy Rating; Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2538047827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538047827?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:32","pubTimestamp":1748431939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S01AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4596","BK4566","BK4559","BK4588","BK4007","BK4557","TEVA","BK4584","BK4585"],"gpt_icon":0},{"id":"2538478597","title":"BUZZ-Veru rises as combo drug shows fewer side effects than semaglutide alone in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2538478597","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538478597?lang=en_us&edition=fundamental","pubTime":"2025-05-28 19:19","pubTimestamp":1748431148,"startTime":"0","endTime":"0","summary":"BUZZ-Veru rises as combo drug shows fewer side effects than semaglutide alone in trial** Shares of weight-loss drug developer of Veru VERU.O rise 46% to 74 cents premarket** VERU says combination of its experimental drug, enobosarm, and semaglutide resulted in fewer gastrointestinal side effects such as diarrhea and nausea in mid-stage trial, compared with semaglutide alone** Combo drug met main goal of mid-stage trial earlier this year** Patients taking enobosarm 3mg with semaglutide saw 99% loss of fat while preserving lean muscle mass, co says** VERU has requested meeting with U.S. FDA to discuss next steps for enobosarm, including potential late-stage trial** As of last close, stock down 21.8% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nL3N3S00S5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4007","VERU","BK4584","BK4557"],"gpt_icon":0},{"id":"2538574427","title":"Veru Reports Positive Safety Results From Phase 2B Quality Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone","url":"https://stock-news.laohu8.com/highlight/detail?id=2538574427","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538574427?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:30","pubTimestamp":1748428217,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S00NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4007","BK4557","VERU","BK4183"],"gpt_icon":0},{"id":"2538427908","title":"Veru Inc - Requests End of Phase 2 Meeting With FDA for Phase 3 Regulatory Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2538427908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538427908?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:30","pubTimestamp":1748428217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S00NU:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERU","BK4584","BK4007","BK4557","BK4183"],"gpt_icon":0},{"id":"2538427653","title":"Veru Inc: Trial Met Its Prespecified Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2538427653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538427653?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:30","pubTimestamp":1748428217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S00NU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4557","VERU","BK4183","BK4584"],"gpt_icon":0},{"id":"2538427520","title":"Veru Inc - Topline Data for Phase 2B Extension Study Expected in Second Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2538427520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538427520?lang=en_us&edition=fundamental","pubTime":"2025-05-28 18:30","pubTimestamp":1748428217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nFWN3S00NU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4584","VERU","BK4557","BK4007"],"gpt_icon":0},{"id":"2538985428","title":"NSW considers moving Sydney Harbour’s last working port for homes","url":"https://stock-news.laohu8.com/highlight/detail?id=2538985428","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538985428?lang=en_us&edition=fundamental","pubTime":"2025-05-28 11:21","pubTimestamp":1748402460,"startTime":"0","endTime":"0","summary":"The NSW government has not ruled out moving Sydney Harbour’s last working port from Glebe Island, west of the CBD, to make way for urgently needed housing around a planned new metro station.After the Australian Turf Club rejected a proposed $5 billion sale of the Rosehill racecourse to make way for 25,000 new homes, Premier Chris Minns promised the government would deliver “new initiatives to have more housing closer to Sydney’s CBD” even if new developments might “ruffle a few feathers in the process”.Loading...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/politics/nsw-considers-moving-sydney-harbour-s-last-working-port-for-homes-20250527-p5m2pk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK4557","ACB","BK4007"],"gpt_icon":0},{"id":"2538841914","title":"Avecho Biotechnology Secures R&D Tax Incentive to Advance CBD Insomnia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2538841914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538841914?lang=en_us&edition=fundamental","pubTime":"2025-05-28 09:38","pubTimestamp":1748396287,"startTime":"0","endTime":"0","summary":"Avecho Biotechnology Limited ( ($AU:AVE) ) has issued an announcement. Avecho Biotechnology Limited has received $1.66 million under the Australian...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avecho-biotechnology-secures-rd-tax-incentive-to-advance-cbd-insomnia-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avecho-biotechnology-secures-rd-tax-incentive-to-advance-cbd-insomnia-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","CBD","BK4007","ACB","BK4113"],"gpt_icon":0},{"id":"2538940413","title":"Aurora Labs Enters U.S. Aerospace Market with Mayman Aerospace Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2538940413","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538940413?lang=en_us&edition=fundamental","pubTime":"2025-05-28 08:08","pubTimestamp":1748390918,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aurora Labs ( ($AU:A3D) ). Aurora Labs has signed a Memorandum of Understanding with Mayman Aerospace to explor...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-labs-enters-u-s-aerospace-market-with-mayman-aerospace-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-labs-enters-u-s-aerospace-market-with-mayman-aerospace-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","ACB","BK4007"],"gpt_icon":0},{"id":"2538497864","title":"Teva receives FDA Fast Track designation for TEV-53408, an anti-IL-15 antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2538497864","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538497864?lang=en_us&edition=fundamental","pubTime":"2025-05-28 05:35","pubTimestamp":1748381717,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA granted Fast Track designation for investigational TEV-53408, an anti-IL-15 antibody, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-receives-fda-fast-track-designation-for-tev-53408-an-anti-il-15-antibody-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-receives-fda-fast-track-designation-for-tev-53408-an-anti-il-15-antibody-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEVA","BK4559","BK4567","IE00BYQQ9H92.USD","FAST","IE00B5TLWC47.USD","BK4588","IE00BFXG0V08.USD","BK4007","BK4104","BK4566","BK4584","BK4557","BK4585","BK4596"],"gpt_icon":0},{"id":"2538494884","title":"Teva initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2538494884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538494884?lang=en_us&edition=fundamental","pubTime":"2025-05-28 04:15","pubTimestamp":1748376908,"startTime":"0","endTime":"0","summary":"Truist initiated coverage of Teva (TEVA) with a Buy rating and $25 price target Teva’s dual focus on cultivating its high-margin brands while stren...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4588","BK4559","BK4596","BK4007","BK4566","TEVA","BK4557","BK4585"],"gpt_icon":0},{"id":"2538491466","title":"Cumberland Pharmaceuticals Unveils Study Confirming Caldolor® as Safe and Effective Opioid-Sparing Pain Management for Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2538491466","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538491466?lang=en_us&edition=fundamental","pubTime":"2025-05-28 04:05","pubTimestamp":1748376346,"startTime":"0","endTime":"0","summary":"Cumberland Pharmaceuticals Unveils Study Confirming Caldolor as Safe and Effective Opioid-Sparing Pain Management for Older Adults. NASHVILLE, Tenn., May 27, 2025/PRNewswire/ -- Cumberland Pharmaceuticals Inc.  has announced the publication of a new clinical study assessing Caldolor  in patients aged 60 and older. The research, aimed at evaluating the drug's safety and efficacy, demonstrated a 23% reduction in morphine use, suggesting a potential opioid-sparing role for Caldolor in pain management among older adults. The study's findings highlight Caldolor's favorable safety profile and its applicability across a broad age range, from infants to older adults. This development marks a significant advancement in addressing the pain management needs of the aging population. Further outreach to healthcare providers is planned to communicate these findings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL2yzZbT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4007","CPIX"],"gpt_icon":0},{"id":"2538495802","title":"Cantor Fitzgerald Remains a Buy on Aurora Innovation (AUR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2538495802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538495802?lang=en_us&edition=fundamental","pubTime":"2025-05-28 00:15","pubTimestamp":1748362534,"startTime":"0","endTime":"0","summary":"In a report released today, Andres Sheppard from Cantor Fitzgerald reiterated a Buy rating on Aurora Innovation (AUR – Research Report), with a pri...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-aurora-innovation-aur?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-aurora-innovation-aur?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4007","AUR","BK4023","BK4557","ACB"],"gpt_icon":0},{"id":"2538461244","title":"Teva Pharmaceutical Industries Begins Preclinical Testing of Inflammation Drug BD9","url":"https://stock-news.laohu8.com/highlight/detail?id=2538461244","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538461244?lang=en_us&edition=fundamental","pubTime":"2025-05-27 21:21","pubTimestamp":1748352118,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries  said Tuesday that it has started preclinical \"IND-enabling\" studies for BD9, an experimental treatment for atopic dermatitis and asthma developed in partnership with Biolojic Design.Teva said the investigational therapy, known as BD9, targets IL-13 and TSLP, two proteins associated with TH2-driven inflammation.Teva has exclusive global development rights to the drug through a licensing agreement with Biolojic and Biolojic may receive milestone payments tied to BD9's progress through development and commercialization, Teva said.Shares of Teva were up 2.7% in recent Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4559","BK4007","BK4588","BK4557","BK4566","TEVA","BK4596","BK4585","BK4584"],"gpt_icon":0},{"id":"2538466086","title":"Teva and Biolojic Design Initiate Ind-Enabling Studies of Bd9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2538466086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538466086?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nTUA1WZGM2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","BK4566","BK4588","BK4007","BK4596","BK4584","BK4557","BK4585","BK4559"],"gpt_icon":0},{"id":"2538466038","title":"Teva Pharmaceutical Industries Ltd - Biolojic to Receive Milestone Payments for Bd9 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2538466038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538466038?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nTUA1WZGM2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","TEVA","BK4557","BK4588","BK4585","BK4559","BK4566","BK4596","BK4007"],"gpt_icon":0},{"id":"2538515463","title":"Aurora Cannabis Announces Virtual Annual Meeting for August 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2538515463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538515463?lang=en_us&edition=fundamental","pubTime":"2025-05-27 19:18","pubTimestamp":1748344681,"startTime":"0","endTime":"0","summary":"An announcement from Aurora Cannabis ( ($TSE:ACB) ) is now available. Aurora Cannabis Inc. has announced its upcoming Annual General and Special Me...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-cannabis-announces-virtual-annual-meeting-for-august-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-cannabis-announces-virtual-annual-meeting-for-august-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4557","ACB"],"gpt_icon":0},{"id":"2538450054","title":"Organigram's CEO Beena Goldenberg to Retire in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2538450054","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538450054?lang=en_us&edition=fundamental","pubTime":"2025-05-27 18:45","pubTimestamp":1748342758,"startTime":"0","endTime":"0","summary":"Organigram Global (OGI) said Tuesday that Beena Goldenberg will retire as the company's chief executive, effective Sept. 30.Goldenberg joined Organigram in 2021 as CEO, the company said, adding that it is planning to initiate a search for its new CEO.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4557","BK4007","OGI"],"gpt_icon":0},{"id":"2538438355","title":"Avecho Secures Major Partnership with Sandoz for CBD Sleep Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2538438355","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538438355?lang=en_us&edition=fundamental","pubTime":"2025-05-27 10:42","pubTimestamp":1748313735,"startTime":"0","endTime":"0","summary":"The latest update is out from Avecho Biotechnology Limited ( ($AU:AVE) ). Avecho Biotechnology Limited announced a significant partnership with glo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avecho-secures-major-partnership-with-sandoz-for-cbd-sleep-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avecho-secures-major-partnership-with-sandoz-for-cbd-sleep-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBD","BK4007","BK4113","BK4557","ACB"],"gpt_icon":0},{"id":"2538049765","title":"What higher building heights could bring for Singapore’s land use and urban planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2538049765","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538049765?lang=en_us&edition=fundamental","pubTime":"2025-05-27 10:18","pubTimestamp":1748312316,"startTime":"0","endTime":"0","summary":"Relaxing building height restrictions imposed by flight paths will improve land intensification, but require much planning and infrastructure support","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/property/what-higher-building-heights-could-bring-singapores-land-use-and-urban-planning","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/property/what-higher-building-heights-could-bring-singapores-land-use-and-urban-planning","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["PLAB","BK4007","BK4147","BK4585","CBD","BK4113","ACB","BK4557","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":63,"code":"91000000","status":"200"}]}}